SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Richard Singer who wrote (3177)12/10/1997 9:39:00 AM
From: Frostman  Read Replies (1) | Respond to of 23519
 
Thanks Richard, what can I say? Another fun day in the big city. I wish Vivus would have mentioned this strategy earlier on. I for one, was under the impression that the real danger to price was, uh, external at this date based on what was said at Q3 earnings interview, and since that time through press releases,published stories, broker up-grades, and threading (competitive and non-competitive).



To: Richard Singer who wrote (3177)12/10/1997 11:52:00 AM
From: Roland Kahn  Read Replies (1) | Respond to of 23519
 
Richard why would cogs go down? Wouldn't it go up as it is spread over fewer units?



To: Richard Singer who wrote (3177)12/11/1997 11:54:00 PM
From: Cacaito  Read Replies (2) | Respond to of 23519
 
Richard's estimates:

Total Operating Expense: $15,454.000

Interest income: $1,106,000 (this presumably from the $100,000,000 milliom marketable securities)

Does this include the New Plant building expenses?

Does anybody knows the actual New Plant building expenses?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News